Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells-Reference-Cited by-同舟云学术

Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells

Published:2007-12 Issue:12 Volume:1771 Page:1407-1417
ISSN:1388-1981
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Author:

Gouazé-Andersson Valérie,Yu Jing Y.,Kreitenberg Adam J.,Bielawska Alicja,Giuliano Armando E.,Cabot Myles C.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference62 articles.

1. Mechanisms of cancer drug resistance;Gottesman;Annu. Rev. Med.,2002

2. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein;Ueda;Biochem. Biophys. Res. Commun.,1986

3. The ABC transporter genes of Plasmodium falciparum and drug resistance;Peel;Drug Resist. Updat.,2001

4. ABC transporters in Leishmania and their role in drug resistance;Ouellette;Drug Resist. Updat.,1998

5. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy;Gouaze;Mol. Cancer Ther.,2004

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism—An Unconventional Ally in Cancer Treatment;International Journal of Molecular Sciences;2024-09-11

2. Insights into molecular mechanisms of chemotherapy resistance in cancer;Translational Oncology;2024-04

3. Characterization of chemoresistant human non-small cell lung cancer cells by metabolic and lipidomic profiling;Metabolomics;2023-09-10

4. Effects and Mechanisms of Action of Preussin, a Marine Fungal Metabolite, against the Triple-Negative Breast Cancer Cell Line, MDA-MB-231, in 2D and 3D Cultures;Marine Drugs;2023-03-04

5. Characterization of chemoresistant human non-small cell lung cancer cells by metabolic and lipidomic profiling;2023-03-02